Industry News
Medevise Consulting Achieves ISO13485 Certification

Medevise Consulting, a strategic consultancy specializing in the ophthalmic sector, announced that i...

read more
Medevise Consulting Achieves ISO13485 Certification
April 16, 2024
Ocular Therapeutix Appoints Pravin U. Dugel, MD, President and CEO

Ocular Therapeutix announced a significant shift in its leadership structure, as Executive Chairman,...

read more
Ocular Therapeutix Appoints Pravin U. Dugel, MD, President and CEO
April 16, 2024
Kiora Pharmaceuticals Receives Funding for Inherited Retinal Disease Trials

Kiora Pharmaceuticals announced that it has secured a grant from the Choroideremia Research Foundati...

read more
Kiora Pharmaceuticals Receives Funding for Inherited Retinal Disease Trials
April 15, 2024
Oasis Medical Introduces New Tapered Plug for Dry Eye Treatment

Oasis Medical has recently unveiled its latest product, the SOFT PLUG Extended Duration 180-T Tapere...

read more
Oasis Medical Introduces New Tapered Plug for Dry Eye Treatment
April 11, 2024
FDA Approves Ocugen's Phase 3 Trial for RP Gene Therapy

Ocugen has received approval from the FDA for an amendment to their investigational new drug (IND) a...

read more
FDA Approves Ocugen's Phase 3 Trial for RP Gene Therapy
April 09, 2024
TheiaNova Eyes Major Funding for Keratoconus Therapy

New Zealand-based biotech firm TheiaNova made a significant appearance as a finalist at the Eyeceler...

read more
TheiaNova Eyes Major Funding for Keratoconus Therapy
April 08, 2024
Orbis and FundamentalVR Launch Innovative VR Solution for Cataract Surgery Training

At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, ...

read more
 Orbis and FundamentalVR Launch Innovative VR Solution for Cataract Surgery Training
April 08, 2024
Vance Thompson, MD, Becomes New President of ASCRS

The American Society of Cataract and Refractive Surgery (ASCRS) is poised to welcome Vance Thompson,...

read more
Vance Thompson, MD, Becomes New President of ASCRS
April 05, 2024
Carl Zeiss Meditec Completes Acquisition of Dutch Ophthalmic Research Center

Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Resea...

read more
Carl Zeiss Meditec Completes Acquisition of Dutch Ophthalmic Research Center
April 05, 2024
Qlaris Bio Advances QLS‑111 into Phase 2 Trials for Ocular Hypertension and Glaucoma Treatment

Qlaris Bio has commenced two critical Phase 2 trials in the United States for its innovative intraoc...

read more
Qlaris Bio Advances QLS‑111 into Phase 2 Trials for Ocular Hypertension and Glaucoma Treatment
April 04, 2024
More